Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Q1 Revenues Fall 2 Percent as R&D Spending Swells

NEW YORK, April 22 (GenomeWeb News) - Gene Logic today said that first-quarter revenues fell 2 percent to $19.7 million from $20.2 million year over year.

Net loss for the three months ended March 31 improved 25 percent to $4 million, or $0.13 per basic share, from $5 million, or $0.18 per basic share, in the year ago period.

Gene Logic spent $1.5 million on R&D in the period, compared to $300,000 in the first quarter of last year.

As of March 31, Gene Logic said it had around $64 million in cash and cash equivalents on hand.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.